Answers are grounded in this paper and cite their sources.
// Alessio Naccarati 1, 2 , Fabio Rosa 3 , Veronika Vymetalkova 2, 4 , Elisa Barone 5 , Katerina Jiraskova 2, 4 , Cornelia Di Gaetano 3, 6 , Jan Novotny 7 , Miroslav Levy 8 , Ludmila Vodickova 2, 4 , Federica Gemignani 5 , Tomas Buchler 9 , Stefano Landi 5 , Pavel Vodicka 2, 4, * , Barbara Pardini 3, 6, * 1 Molecular and Genetic Epidemiology Research Unit, Human Genetics Foundation, Turin, Italy 2 Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Prague, Czech Republic 3 Genomic Variation in Human Populations and Complex Diseases Research Unit, Human Genetics Foundation, Turin, Italy 4 Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic 5 Department of Biology, University of Pisa, Pisa, Italy 6 Department of Medical Sciences, University of Turin, Turin, Italy 7 Department of Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic 8 Department of Surgery, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic 9 Department of Oncology, Thomayer Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic * These authors contributed equally to this work Correspondence to: Alessio Naccarati, e-mail: alessio.naccarati@hugef-torino.org Keywords: double-strand break repair (DSBR) genes, colorectal cancer risk and clinical outcomes, miRNA binding sites, 3′UTR polymorphisms, MRE11A Received: July 07, 2015 Accepted: December 09, 2015 Published: December 31, 2015 ABSTRACT Genetic variations in 3′ untranslated regions of target genes may affect microRNA binding, resulting in differential protein expression. microRNAs regulate DNA repair, and single-nucleotide polymorphisms in miRNA binding sites (miRSNPs) may account for interindividual differences in the DNA repair capacity. Our hypothesis is that miRSNPs in relevant DNA repair genes may ultimately affect cancer susceptibility and impact prognosis. In the present study, we analysed the association of polymorphisms in predicted microRNA target sites of double-strand breaks (DSBs) repair genes with colorectal cancer (CRC) risk and clinical outcome. Twenty-one miRSNPs in non-homologous end-joining and homologous recombination pathways were assessed in 1111 cases and 1469 controls. The variant CC genotype of rs2155209 in MRE11A was strongly associated with decreased cancer risk when compared with the other genotypes (OR 0.54, 95% CI 0.38–0.76, p = 0.0004). A reduced expression of the reporter gene was observed for the C allele of this polymorphism by in vitro assay, suggesting a more efficient interaction with potentially binding miRNAs. In colon cancer patients, the rs2155209 CC genotype was associated with shorter survival while the TT genotype of RAD52 rs11226 with longer survival when both compared with their respective more frequent genotypes (HR 1.63, 95% CI 1.06-2.51, p = 0.03 HR 0.60, 95% CI 0.41–0.89, p = 0.01, respectively). miRSNPs in DSB repair genes involved in the maintenance of genomic stability may have a role on CRC susceptibility and clinical outcome.
No takes yet. Share an insight, caveat, or question.
Naccarati et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: